As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

AAPS PharmSciTech High Impact Article Award Recognizing an article published in the last two years in AAPS PharmSciTech that is judged exceptional by the editors for its impact on pharmaceutical technology.

Awardee/Corresponding Author: Peter Mack, Ph.D., Astrazeneca Co-Authors: Amber Doty, Jon Schroeder, Kou Vang, Mark Sommerville, Ph.D., Mervin Taylor, Brad Flynn, and David Lechuga-Ballesteros, Ph.D.

Watch the video here.

Congratulations to the 2020 Outstanding Manuscript Award Winner in AAPS PharmSciTech

Each year AAPS recognizes outstanding contributions to original research published in three of its journals: Pharmaceutical Research, AAPS PharmSciTech, and The AAPS Journal. The Outstanding Manuscript Awards are selected by each journal’s chief editor and are based on a manuscript published in the respective journal that is deemed to have had a high impact on the pharmaceutical sciences community.

For AAPS PharmSciTech, this award was given to Peter Mack, Ph.D., AstraZeneca (as Corresponding Author; Co-authors are Amber Doty, Jon Schroeder, Kou Vang, Mark Sommerville, Ph.D., Mervin Taylor, Brad Flynn, and David Lechuga-Ballesteros, Ph.D.) for the article “Drug Delivery from an Innovative LAMA/LABA Co-suspension Delivery Technology Fixed-Dose Combination MDI: Evidence of Consistency, Robustness, and Reliability